KeyBank National Association’s Dianthus Therapeutics DNTH Stock Holding History

KeyBank National Association’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Buy	+3,510	New	+$307K	﹤0.01%	1082

Other funds holding DNTH

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

PFA

Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

KeyBank National Association's DNTH Position: Q2 2026 in Review

KeyBank National Association opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 3,510 shares worth $342K. The stake represents ﹤0.01% of the portfolio and ranks #1082 among its holdings.

25 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

KeyBank National Association held 3,510 shares of Dianthus Therapeutics worth $342K as of Q2 2026.
Dianthus Therapeutics was a new KeyBank National Association position in Q2 2026.
Dianthus Therapeutics made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #1082 holding.
25 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.